TBIO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Stats
Today's Volume	23 545.00
Average Volume	762 159
Market Cap	9.68M
EPS	$0 ( 2024-04-02 )
Next earnings date	( $-0.140 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.200
ATR14	$0.00700 (2.01%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-17	Esser Eric Eugene	Buy	200 000	Stock Option (right to buy)
2024-04-17	Esser Eric Eugene	Buy	100 000	Common Stock
2023-06-22	Nelson Todd Robert	Buy	385 500	Stock Option (right to buy)
2023-06-22	Nelson Todd Robert	Buy	47 700	Common Stock
2024-03-01	Nelson Todd Robert	Sell	4 756	Common Stock

INSIDER POWER
95.80
Last 89 transactions
Buy: 85 527 522 \| Sell: 75 379 307

Volume Correlation

Long: -0.14 (neutral)

Short: 0.91 (very strong)

Signal:(60.229) Expect same movement, but be aware

Translate Bio Inc Correlation

10 Most Positive Correlations
GMII	0.905
AFYA	0.889
EAR	0.88
TRMK	0.878
XPDI	0.874
WASH	0.872
ATSG	0.864
ALHC	0.863
GOOD	0.862
CSSEP	0.86

10 Most Negative Correlations
DRNA	-0.948
SUMO	-0.941
OCSL	-0.925
CMPI	-0.908
ALBO	-0.906
MIGI	-0.895
IMAQ	-0.893
TCBC	-0.892
ZIONP	-0.89
XM	-0.89

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Translate Bio Inc Correlation - Currency/Commodity

-0.09
( neutral )

-0.10
( neutral )

0.00
( neutral )

0.02
( neutral )

Translate Bio Inc Financials

Annual	2023
Revenue:	$27.51M
Gross Profit:	$12.85M (46.70 %)
EPS:	$-1.600

Q4	2023
Revenue:	$6.98M
Gross Profit:	$4.10M (58.71 %)
EPS:	$-0.590

Q3	2023
Revenue:	$5.56M
Gross Profit:	$3.00M (53.86 %)
EPS:	$-0.350

Q2	2023
Revenue:	$8.65M
Gross Profit:	$5.69M (65.80 %)
EPS:	$-0.280

Financial Reports:

No articles found.

Translate Bio Inc

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.